查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198212

呼吸监测市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Respiratory Monitoring Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，呼吸监测市场预计将以 9.5% 的复合年增长率增长。

COVID-19 的爆发对呼吸监测市场产生了重大影响。 由于需要连续呼吸监测的 COVID-19 病例增加，在 COVID-19 流行期间，对呼吸监测设备的需求显着增长。 此外，根据 2021 年 6 月发表在 MDPI 期刊上的一项研究，较低的二氧化碳水平与 COVID-19 患者的死亡风险增加有关。 因此，二氧化碳图分析可以成为跟踪 COVID-19 患者 CO2 水平的有用方法。 预计这些好处将推动市场超越大流行。 此外，根据美敦力 2022 年年度报告，COVID-19 已经并将继续对呼吸监测的增长产生负面影响。 它还表示，在 2022 财年用于 NICU 的 Nellcor 脉搏血氧饱和度传感器和 SonarMed 气道监测系统的推动下，呼吸监测将继续被接受和增长。 因此，上述因素表明，大流行影响了各种呼吸监测设备的日益普及，从而推动了增长。

由于呼吸道疾病增多、吸烟率高以及呼吸监测市场先进技术的开发，预计呼吸监测市场将出现快速增长。 例如，据世界卫生组织称，到 2021 年，慢性呼吸道疾病将影响全球超过 10 亿人。 此外，根据 Lung India 截至 2022 年 8 月的数据，2021 年，印度儿童哮喘的患病率约为 18.2%。 此外，根据国际呼吸学会论坛 2022 年报告，估计约有 2 亿人患有慢性阻塞性肺病，2.62 亿人患有哮喘。 此外，根据 FDA 和 CDC 于 2022 年 11 月发布的 2022 年全国青年烟草调查的联邦数据，超过十分之一的中学生（308 万）将在 2022 年 10 月至 2022 年 11 月期间使用烟草产品。好像有16.5%的高中生和4.5%的初中生用过无烟。 如此高的呼吸系统疾病患病率和高吸烟率预计将增加对呼吸监测的需求，并最终在预测期内推动市场。

此外，主要市场参与者推出的各种产品支持预测期内的市场扩张。 例如，2021 年 3 月，Vyaire Medical 在英国推出了创新的远程 Aiocare 移动肺量计。 该设备有助于快速诊断肺部疾病，例如哮喘和慢性阻塞性肺病，准确度可与医院级肺活量计相媲美。 此类产品的推出有望在预测期内推动呼吸监测市场的增长。 此外，製药公司的各种举措正在推动市场的增长。 例如，2021 年 11 月，Smile Train 和 Lifebox 发布了二氧化碳图设备的征求建议书 (RFP)，以帮助 Smile Train 的合作医院为儿童提供完整和安全的裂伤护理。 预计此类公司的市场发展将在预测期内带动市场。

然而，报销问题和监控设备的高价格预计会抑制市场增长。

呼吸监测市场趋势

预计在预测期内肺活量计部分将实现高增长

肺活量计是一种测量进出肺部的空气量的设备。 使用肺活量计测量进出肺部的空气。 在肺活量图上可以看到异常的阻塞性抑制通气模式。 由于 COPD、哮喘和肺结核等慢性呼吸系统疾病的日益流行以及肺活量计的技术改进，预计该领域将会增长。 例如，根据 2021 年 7 月发表在 MDPI Diagnostics 上的一项研究，COPD 在澳大利亚为 14.5%，在中国为 4.4%-16.7%，在印度尼西亚为 5.6%，COPD（哮喘根除后）在日本为 8.6%，预计韩国13.4%，马来西亚4.7%，台湾5.4%-6.1%，泰国3.7%-6.8%，菲律宾3.5%-20.8%，越南6%。 这样，随着呼吸系统疾病的增加，对监测的需求有望增加，这有望推动该领域的增长。

此外，为了保持市场竞争力，企业正在推动先进技术的开发、新产品的推出以及与市场参与者的战略联盟。 例如，Cipla Limited 在 2021 年 11 月的世界慢性阻塞性肺病日推出了印度首款基于 pneumotouch 的手持式无线肺量计“Spirofy”。 通过此次发布，该公司打算彻底改变阻塞性气道疾病（ OAD ）诊断，以符合其加强其在印度肺部领导者地位的雄心。 预计此类产品的推出将在预测期内推动细分市场的增长。

因此，由于上述因素，预计肺活量计领域在未来几年将呈现显着增长。

预计在预测期内北美将主导呼吸监测市场

北美在呼吸监测市场占据主导地位，这主要是由于呼吸系统疾病患病率上升。 此外，该国的人均医疗保健支出正在增加，并且由于失业率下降，预计在预测期内会增加。 根据美国哮喘与过敏基金会的数据，截至 2021 年 4 月，美国每年将有超过 2000 万 18 岁及以上的人患有哮喘病。 因此，该国出现此类症状的频率表明对呼吸设备的稳定需求，导緻美国研究市场的增长。 根据 2022 年 7 月发表在 Pulmonary Therapy 上的一项研究，最常见的呼吸道症状是排痰性咳嗽和呼吸急促后影响 17% 的美国成年人。 因此，随着呼吸系统疾病负担的增加，预计在预测期内对呼吸监测设备的需求将增加，从而推动市场增长。

此外，该地区市场参与者对先进技术的开发也为市场的扩张提供了支持。 例如，2022 年 3 月，总部位于美国的呼吸保健技术公司 Respira Labs 推出了一款由人工智能驱动的可穿戴肺部监测仪，该监测仪使用声共振来评估肺功能并识别肺气量的波动。发布了“Sylvee”。 我们支持慢性阻塞性肺病 (COPD)、哮喘和 COVID-19 的早期检测和治疗。 此外，2022 年 3 月，呼吸健康管理公司 Respiri 在美国密歇根州的一家儿童医院启动了首个报销远程患者监护 (RPM) 试点项目。 预计市场参与者的这种努力将在预测期内推动市场增长。

呼吸监测市场竞争对手分析

由于公司在全球和区域开展业务，呼吸监测市场不景气。 竞争格局包括知名国际公司和本地公司分析。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 呼吸道疾病增加
    • 吸烟率高
    • 先进技术的开发
  • 市场製约因素
    • 报销问题
    • 监控设备价格高
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

  • 按设备类型
    • 肺量计
    • 峰值流量计
    • 睡眠测试设备
    • 气体分析仪
    • 脉搏血氧计
    • 二氧化碳图
    • 其他设备
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Airsep Corporation
    • Medtronic（Covidien）
    • Draegerwerk
    • GE Healthcare
    • Hamilton Medical
    • Getinge Inc.
    • Philips Healthcare
    • Resmed
    • Siemens Healthcare
    • Vyaire Medical, Inc.
    • Nihon Kohden Corporation
    • Smiths Medical

第7章 市场机会与今后动向

简介目录
Product Code: 52772

The respiratory monitoring market is expected to register a CAGR of 9.5% over the forecast period.

The outbreak of COVID-19 impacted the respiratory monitoring market significantly. The demand for respiratory monitoring devices has witnessed significant growth during the COVID-19 pandemic due to the increasing number of COVID-19 cases which require continuous respiratory monitoring. Additionally, as per the study published in MDPI Journal in June 2021, lower CO2 levels were associated with an increased risk of death in COVID-19 patients. Hence, analysis of the capnogram can therefore be a useful method for tracking CO2 levels in COVID-19 patients. Such an advantage is expected to drive the market over the pandemic. Furthermore, as per Medtronic's 2022 annual report, COVID-19 is having, and will continue to have, an adverse impact on increasing respiratory monitoring. It also stated that there is a continuous acceptance and growth in respiratory monitoring, led by the Nellcor pulse oximetry sensors and SonarMed Airway Monitoring System for the NICU in the fiscal year 2022. Hence, the above-mentioned factor indicated the impact of the pandemic on the rising adoption of various respiratory monitoring devices, thus driving growth.

The respiratory monitoring market will show rapid growth due to the rise in the number of respiratory diseases, the high prevalence of tobacco smoking, and the development of advanced technologies in respiratory monitoring market. For instance, as per WHO, in 2021, chronic respiratory diseases affect more than one billion people globally. Also, as per the data from Lung India as of August 2022, the prevalence of asthma among Indian children was around 18.2%, in 2021. Furthermore, according to the Forum of International Respiratory Societies report 2022, approximately 200 million people are estimated to have COPD, and 262 million people are affected by Asthma. Additionally, in November 2022, FDA and CDC released federal data from the 2022 National Youth Tobacco Survey which showed that in 2022, more than 1 in 10 middle and high school students (3.08 million) had used a tobacco product from October to November 2022 including 16.5% of high school and 4.5% of middle school students out of which 2.4% were smokeless. Such a high prevalence of respiratory disease and the high prevalence of tobacco smoking are expected to increase the demand for respiratory monitoring, eventually driving the market over the forecast period.

Moreover, various product launches by the key market players support the market expansion over the forecast period. For instance, in March 2021, Vyaire Medical launched its innovative remote Aiocare mobile spirometer in the United Kingdom. The device helps promptly diagnose pulmonary diseases such as asthma and COPD as accurately as hospital-grade spirometers. Such product launches are expected to propel the growth of the respiratory monitoring devices market over the forecast period. Additionally, various initiatives taken by the pharmaceutical players propel the market's growth. For instance, in November 2021, Smile Train and Lifebox issued a Request for Proposals (RFP) for a capnography device to help Smile Train partner hospitals provide complete, safe cleft care for children. Such company developments are expected to drive the market over the forecast period.

However, reimbursement concerns and the high price of the monitoring devices are the factors expected to restrain the market growth.

Respiratory Monitoring Market Trends

Spirometer Segment is Expected to Witness High Growth Over the Forecast Period

A spirometer is a device that measures the amount of air that is inspired and expelled by the lungs. The passage of air in and out of the lungs is measured with a spirometer. Obstructive and restrictive aberrant ventilation patterns can be identified by the spirogram. The segment is expected to grow due to the increasing prevalence of chronic respiratory diseases such as COPD, Asthma, TB, etc., and technological improvements in spirometers. For instance, according to the study published in MDPI Diagnostics in July 2021, COPD is projected to be 14.5% in Australia, 4.4% to 16.7% in China, and 5.6% in Indonesia, while COPD (after removing asthmatics) was 8.6% in Japan, 13.4% in Korea, 4.7% in Malaysia, 5.4% to 6.1% in Taiwan, 3.7% to 6.8% in Thailand, 3.5% to 20.8% in the Philippines, and 6.7% in Vietnam, respectively. Thus, with the increasing prevalence of respiratory diseases, the demand for its monitoring is expected to increase, which is likely to propel the growth of the segment.

Furthermore, companies are developing advanced technologies, launching new products, and forming strategic alliances with the market players to stay competitive in the market. For instance, in November 2021, Cipla Limited launched Spirofy, India's first pneumotach based portable, wireless Spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen its position as the lung leader in India. Such launches are expected to drive the segmental growth over the forecast period.

Thus, owing to the above factors, the spirometer segment is expected to show significant growth over the coming years.

North America is Expected to Dominate the Respiratory Monitoring Market Over the Forecast Period

North America has dominated the respiratory monitoring market, and the dominance of the market is mainly attributable to the increasing prevalence of respiratory diseases. Also, there is a rise in per capita health expenditure in the country, which is expected to increase over the forecast period owing to the decrease in the unemployment rate. According to data from the Asthma and Allergy Foundation of America, in April 2021, over 20 million people in the United States aged 18 and above suffer from asthma each year. Thus, the frequency of such conditions in the country implies a steady need for respiratory devices, causing the market under study in the United States to grow. In addition, according to the study published in Pulmonary Therapy in July 2022, the most common respiratory symptom, followed by a productive cough and shortness of breath, affects 17% of adult Americans. Thus, with the growing burden of respiratory diseases, the demand for respiratory monitoring devices is expected to increase over the forecast period, thereby boosting the market's growth.

Additionally, the development of advanced technology by the market players in the region supports market expansion. For instance, in March 2022, Respira Labs, a respiratory healthcare tech business based in the United States, released Sylvee, an AI-powered wearable lung monitor that employs acoustic resonance to assess lung function and identify variations in lung air volume. It aided in the early detection and treatment of chronic obstructive pulmonary disease (COPD), asthma, and COVID-19. Additionally, in March 2022, Respiri, a respiratory health management company, started its first reimbursed remote patient monitoring (RPM) pilot program at the Children's Hospital of Michigan in the United States. Such initiatives by the market players are expected to boost market growth over the forecast period.

Respiratory Monitoring Market Competitor Analysis

The respiratory monitoring market is moderate due to the presence of companies operating globally as well as regionally. The competitive landscape includes an analysis of international as well as local companies which hold significant market shares and are well known including Airsep Corporation, Medtronic (Covidien), Draegerwerk, GE Healthcare, Getinge Inc., Philips Healthcare, Resmed, Siemens Healthcare, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Number of Respiratory Diseases
    • 4.2.2 High Prevalence of Tobacco Smoking
    • 4.2.3 Development of Advanced Technologies
  • 4.3 Market Restraints
    • 4.3.1 Reimbursement Concerns
    • 4.3.2 High Price of the Monitoring Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type of Device
    • 5.1.1 Spirometers
    • 5.1.2 Peak Flow Meters
    • 5.1.3 Sleep Test Devices
    • 5.1.4 Gas Analyzers
    • 5.1.5 Pulse Oximeters
    • 5.1.6 Capnographs
    • 5.1.7 Other Types of Devices
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Airsep Corporation
    • 6.1.2 Medtronic (Covidien)
    • 6.1.3 Draegerwerk
    • 6.1.4 GE Healthcare
    • 6.1.5 Hamilton Medical
    • 6.1.6 Getinge Inc.
    • 6.1.7 Philips Healthcare
    • 6.1.8 Resmed
    • 6.1.9 Siemens Healthcare
    • 6.1.10 Vyaire Medical, Inc.
    • 6.1.11 Nihon Kohden Corporation
    • 6.1.12 Smiths Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS